Has Mahitha Kolli received payments from drug or device companies?

Yes. Drug and device makers reported $4,234 in general payments to Mahitha Kolli across 195 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Mahitha Kolli did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Mahitha Kolli come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Mahitha Kolli

Psychiatry · Gainesville, GANPI 1083098149

Payments from drug & device makers

$4,234in general payments, 2019–2025

Across 195 payments — averaging $21.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Supernus Pharmaceuticals, Inc.$930
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$749
AbbVie$691
Johnson & Johnson$506
Teva Pharmaceuticals USA, Inc.$208
Otsuka America Pharmaceutical, Inc.$200
plus $950 from 14 others

What the payments were for

Food & beverage$4,18799%
Education$471%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Supernus Pharmaceuticals, Inc.	37	$930
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	47	$749
AbbVie	33	$691
Johnson & Johnson	13	$506
Teva Pharmaceuticals USA, Inc.	9	$208
Otsuka America Pharmaceutical, Inc.	9	$200
Neurocrine Biosciences, Inc.	6	$170
Ironshore Pharmaceuticals Inc.	5	$148
Alkermes, Inc.	7	$120
Vanda Pharmaceuticals Inc.	4	$100
Tris Pharma Inc	5	$93
Lundbeck LLC	3	$78
Takeda Pharmaceuticals U.S.A., Inc.	3	$63
Idorsia Pharmaceuticals US Inc	4	$61
Medtronic	1	$27
Collegium Pharmaceutical, Inc.	1	$20
Sunovion Pharmaceuticals Inc.	1	$19
Neos Therapeutics, LP	1	$19
Corium, LLC	5	$17
Vertical Pharmaceuticals, LLC	1	$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,234 in reported general payments places this provider in the 85th percentile of 900 psychiatry providers in Georgia.

See all psychiatry providers in Georgia →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Fluphenazine Hcl	12	$2,441
Clozapine	17	$950
Quetiapine Fumarate	14	$525
Methylphenidate ErMethylphenidate Hcl	11	$291
Lithium Carbonate ErLithium Carbonate	20	$153
Benztropine Mesylate	17	$148
Clonidine Hcl	14	$144

Paid to pharmacies, not to this prescriber.

Other psychiatry in Gainesville

Shahzad HashmiGainesville$672K
Robert RiesenbergAtlanta$51.1M
Saundra Maass-RobinsonAtlanta$11.1M
David PurselleAtlanta$7.4M
Maria JohnsonDecatur$5.4M
Bethany DavisAtlanta$4.4M
Michael BanovMarietta$4.2M
Michael MobleySavannah$2.9M
Richard PettyLoganville$2.9M
Felipe SuplicyRome$2.3M

See the full list for Georgia →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →